Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma

BMC Cancer

Table 1 Clinical characteristics of sarcoma patients

	Training set	Validation set	t/X²	P
Age	60.74 ± 15.29	60.46 ± 13.50	0.141	0.888
Sex			0.198	0.657
Male	79	37
Female	91	48
Race			1.074	0.783
Asian	5	1
African American	11	7
WHITE	149	75
NA	5	2
Histological type			4.753	0.314
LMS	65	37
DLP	34	23
UPS	35	14
MYX	18	7
Other	18	4
Metastasis			1.282	0.527
No	84	36
Yes	34	21
NA	52	28
Surgical margin resection status			0.301	0.860
R0	104	49
R1–2	49	27
NA	17	9
Radiotherapy			0.672	0.715
No	94	43
Yes	46	27
NA	30	15
Multifocal indicator			0.699	0.705
No	131	64
Yes	24	15
NA	15	6

LMS Leiomyosarcoma, DLP Dedifferentiated liposarcoma, UPS Undifferentiated pleomorphic sarcoma, MYX Myxofibrosarcoma

ISSN: 1471-2407